- Home
- SKX vs CORT Comparison
SKX vs CORT Comparison
Compare SKX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- CORT
- Stock Information
- Founded
- SKX 1992
- CORT 1998
- Country
- SKX United States
- CORT United States
- Employees
- SKX N/A
- CORT N/A
- Industry
- SKX Shoe Manufacturing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- SKX Consumer Discretionary
- CORT Health Care
- Exchange
- SKX Nasdaq
- CORT Nasdaq
- Market Cap
- SKX 9.3B
- CORT 8.1B
- IPO Year
- SKX 1999
- CORT N/A
- Fundamental
- Price
- SKX $62.48
- CORT $71.38
- Analyst Decision
- SKX Buy
- CORT Strong Buy
- Analyst Count
- SKX 12
- CORT 4
- Target Price
- SKX $69.18
- CORT $142.00
- AVG Volume (30 Days)
- SKX 5.7M
- CORT 1.4M
- Earning Date
- SKX 07-24-2025
- CORT 07-28-2025
- Dividend Yield
- SKX N/A
- CORT N/A
- EPS Growth
- SKX 9.64
- CORT 8.36
- EPS
- SKX 4.16
- CORT 1.14
- Revenue
- SKX $9,129,335,000.00
- CORT $685,446,000.00
- Revenue This Year
- SKX $7.83
- CORT $35.85
- Revenue Next Year
- SKX $6.94
- CORT $35.22
- P/E Ratio
- SKX $15.03
- CORT $62.59
- Revenue Growth
- SKX 10.66
- CORT 30.93
- 52 Week Low
- SKX $44.50
- CORT $28.10
- 52 Week High
- SKX $78.85
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- SKX 66.76
- CORT 48.38
- Support Level
- SKX $62.41
- CORT $69.60
- Resistance Level
- SKX $62.80
- CORT $73.13
- Average True Range (ATR)
- SKX 0.18
- CORT 3.50
- MACD
- SKX -0.28
- CORT -0.18
- Stochastic Oscillator
- SKX 62.35
- CORT 24.77
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.